Literature DB >> 18704360

[Prevalence of lymph node metastases in non-muscle-invasive bladder cancer. Delay of radical cystectomy and upstaging in the cystectomy specimen as risk factors].

C Wiesner1, C Thomas, A Salzer, R Gillitzer, C Hampel, J W Thüroff.   

Abstract

OBJECTIVE: To study clinical and histopathologic parameters after cystectomy and lymphadenectomy in non-muscle-invasive transitional cell carcinoma (TCC) of the bladder and their association with the prevalence of lymph node metastases (N+). PATIENTS AND METHODS: Of 866 patients treated with radical cystectomy and lymphadenectomy, 219 had non-muscle-invasive TCC of the bladder. The prevalence of N+ was related to parameters such as gender, age, number of transurethral resections of the bladder (TURBs), intervals between first TURB and cystectomy, adjuvant therapy, maximum histopathologic tumor stage and grade at TURB, and tumor upstaging in the cystectomy specimen by univariate and multivariate analysis.
RESULTS: A total of 33 patients (15%) had N+. By multivariate analyses, tumor upstaging and the number of TURBs were independent predictors of N+ at cystectomy. The number of TURBs increased the prevalence of N+ from 8% (one TURB) to 24% (two to four TURBs). Tumor upstaging in the cystectomy specimen increased the prevalence of N+ from 4% to 36%.
CONCLUSION: Inappropriate delay and staging errors of"high risk" non-muscle-invasive TCC of the bladder contribute to an increased prevalence of N+ and should be avoided. In our series, the number of TURBs and tumor upstaging in the cystectomy specimen were independent predictors for N+ by multivariate analysis.

Entities:  

Mesh:

Year:  2008        PMID: 18704360     DOI: 10.1007/s00120-008-1842-y

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  19 in total

1.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Authors:  J P Stein; G Lieskovsky; R Cote; S Groshen; A C Feng; S Boyd; E Skinner; B Bochner; D Thangathurai; M Mikhail; D Raghavan; D G Skinner
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

2.  Contemporary management of stage T1 transitional cell carcinoma of the bladder.

Authors:  Mark S Soloway; Mario Sofer; Anil Vaidya
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

3.  Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin.

Authors:  M Brake; H Loertzer; R Horsch; H Keller
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

4.  Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

Authors:  H W Herr; P C Sogani
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

5.  Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy.

Authors:  Christoph Wiesner; Jesco Pfitzenmaier; Andreas Faldum; Rolf Gillitzer; Sebastian W Melchior; Joachim W Thüroff
Journal:  BJU Int       Date:  2005-02       Impact factor: 5.588

6.  The value of a second transurethral resection in evaluating patients with bladder tumors.

Authors:  H W Herr
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

Review 7.  Multivariate analysis of the prognostic factors of primary superficial bladder cancer.

Authors:  F Millán-Rodríguez; G Chéchile-Toniolo; J Salvador-Bayarri; J Palou; J Vicente-Rodríguez
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

8.  Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?

Authors:  A Brauers; R Buettner; G Jakse
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

9.  Radical cystectomy--often too late?

Authors:  M Stöckle; P Alken; U Engelmann; G H Jacobi; H Riedmiller; R Hohenfellner
Journal:  Eur Urol       Date:  1987       Impact factor: 20.096

10.  Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials.

Authors:  Richard J Sylvester; Adrian P M van der MEIJDEN; Donald L Lamm
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

View more
  1 in total

1.  [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?].

Authors:  M May; M Burger; S Brookman-May; W Otto; J Peter; O Rud; H-M Fritsche; C Bolenz; L Trojan; E Herrmann; M S Michel; C Wülfing; R Moritz; A Tiemann; S C Müller; J Ellinger; A Buchner; C G Stief; D Tilki; W F Wieland; C Gilfrich; T Höfner; M Hohenfellner; A Haferkamp; J Roigas; P Bretschneider-Ehrenberg; O Müller; M Zacharias; S Gunia; P J Bastian
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.